These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11502466)

  • 21. Growth inhibition of cancer cells by an active metabolite of a novel vitamin D prodrug.
    Wang YR; Wigington DP; Strugnell SA; Knutson JC
    Anticancer Res; 2005; 25(6B):4333-9. PubMed ID: 16309237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells.
    Tokar EJ; Webber MM
    Clin Exp Metastasis; 2005; 22(3):265-73. PubMed ID: 16158254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of vitamin D in prostate cancer.
    Zhao XY; Feldman D
    Steroids; 2001; 66(3-5):293-300. PubMed ID: 11179737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression.
    Krishnan AV; Peehl DM; Feldman D
    J Cell Biochem; 2003 Feb; 88(2):363-71. PubMed ID: 12520538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.
    Miller GJ; Stapleton GE; Hedlund TE; Moffat KA
    Clin Cancer Res; 1995 Sep; 1(9):997-1003. PubMed ID: 9816072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study.
    Ryan CJ; Halabi S; Ou SS; Vogelzang NJ; Kantoff P; Small EJ
    Clin Cancer Res; 2007 Apr; 13(7):2030-7. PubMed ID: 17404083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects.
    Yin Y; Ni J; Chen M; Guo Y; Yeh S
    Clin Cancer Res; 2009 Jan; 15(1):190-200. PubMed ID: 19118046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathways mediating the growth-inhibitory actions of vitamin D in prostate cancer.
    Peehl DM; Krishnan AV; Feldman D
    J Nutr; 2003 Jul; 133(7 Suppl):2461S-2469S. PubMed ID: 12840225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of intermediate-dose ketoconazole in hormone refractory prostate cancer.
    Wilkinson S; Chodak G
    Eur Urol; 2004 May; 45(5):581-4; discussion 585. PubMed ID: 15082199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Vitamin D insensitive prostate cancer cells.
    Alagbala AA; Moser MT; Johnson CS; Trump DL; Foster BA
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):712-6. PubMed ID: 17280828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells.
    Serda RE; Bisoffi M; Thompson TA; Ji M; Omdahl JL; Sillerud LO
    Prostate; 2008 May; 68(7):773-83. PubMed ID: 18247401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
    Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R
    Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibition of steroidogenesis by ketoconazole. Therapeutic uses].
    Miossec P; Archambeaud-Mouveroux F; Teissier MP
    Ann Endocrinol (Paris); 1997; 58(6):494-502. PubMed ID: 9686009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibitors of the key enzymes of androgen synthesis: potential agents as targets for prostate cancer].
    Takeda M; Hosaka M
    Nihon Rinsho; 2000 Jul; 58 Suppl():312-6. PubMed ID: 11022738
    [No Abstract]   [Full Text] [Related]  

  • 35. Ketoconazole high dose in management of hormonally pretreated patients with progressive metastatic prostate cancer. Dutch South-Eastern Urological Cooperative Group.
    Witjes FJ; Debruyne FM; Fernandez del Moral P; Geboers AD
    Urology; 1989 May; 33(5):411-5. PubMed ID: 2652864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells.
    Tokar EJ; Webber MM
    Clin Exp Metastasis; 2005; 22(3):275-84. PubMed ID: 16158255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired cutaneous adherence in patients with androgen-independent prostate cancer receiving ketoconazole and doxorubicin: medication-induced sticky skin.
    Polsen JA; Cohen PR; Sella A
    J Am Acad Dermatol; 1995 Apr; 32(4):571-5. PubMed ID: 7534776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
    Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
    Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infantile hypercalcemia and hypercalciuria: new insights into a vitamin D-dependent mechanism and response to ketoconazole treatment.
    Nguyen M; Boutignon H; Mallet E; Linglart A; Guillozo H; Jehan F; Garabedian M
    J Pediatr; 2010 Aug; 157(2):296-302. PubMed ID: 20394945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity.
    Swami S; Krishnan AV; Peehl DM; Feldman D
    Mol Cell Endocrinol; 2005 Sep; 241(1-2):49-61. PubMed ID: 15955619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.